Search research articles
Contact Us
Filters
Showing results (21-30 of 64) with videos related to
Page
of 7
Sort By:
Plos Genetics
|
June 28, 2008
Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma
Anna Foryst-Ludwig, Markus Clemenz, Stephan Hohmann, et al.
Clinical Lung Cancer
|
March 2, 2021
Pembrolizumab as First-Line Palliative Therapy in PD-L1 Overexpressing (≥ 50%) NSCLC: Real-world Results with Special Focus on PS ≥ 2, Brain Metastases, and Steroids
Nikolaj Frost, Jens Kollmeier, Daniel Misch, et al.
Current Oncology (Toronto, Ont.)
|
December 24, 2025
Independent Validation of a Machine Learning Classifier for Predicting Mediastinal Lymph Node Metastases in Non-Small Cell Lung Cancer Using Routinely Obtainable [<sup>18</sup>F]FDG-PET/CT Parameters
Agata Wdowiak, Julian M M Rogasch, Georg L Baumgärtner, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 23, 2023
A machine learning tool to improve prediction of mediastinal lymph node metastases in non-small cell lung cancer using routinely obtainable [<sup>18</sup>F]FDG-PET/CT parameters
Julian M M Rogasch, Liza Michaels, Georg L Baumgärtner, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 22, 2019
Next generation sequencing of lung adenocarcinoma subtypes with intestinal differentiation reveals distinct molecular signatures associated with histomorphology and therapeutic options
Philipp Jurmeister, Claudia Vollbrecht, Anke Behnke, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 17, 2021
FDG-PET/CT for pretherapeutic lymph node staging in non-small cell lung cancer: A tailored approach to the ESTS/ESMO guideline workflow
Julian M M Rogasch, Nikolaj Frost, Stephanie Bluemel, et al.
BMC Health Services Research
|
July 3, 2025
Recruiting patients into a healthcare services trial: lessons learned from a feasibility study to investigate a patient-oriented navigation intervention for age-associated diseases
Kathrin Gödde, Hella Fügemann, Ulrike Grittner, et al.
JAMA Network Open
|
April 29, 2022
Effectiveness of Immune Checkpoint Inhibition vs Chemotherapy in Combination With Radiation Therapy Among Patients With Non-Small Cell Lung Cancer and Brain Metastasis Undergoing Neurosurgical Resection
David Wasilewski, Josefine Radke, Ran Xu, et al.
Current Medical Research and Opinion
|
September 1, 2022
Prophylaxis of chemotherapy-induced neutropenia with lipegfilgrastim in patients with lung cancer: final results from the non-interventional study NADIR
Christian Geßner, Thomas Fietz, Christoph Losem, et al.
Therapeutic Advances in Medical Oncology
|
June 9, 2022
Clinical predictors of survival in patients with relapsed/refractory small-cell lung cancer treated with checkpoint inhibitors: a German multicentric real-world analysis
Jan A Stratmann, Radha Timalsina, Akin Atmaca, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 64) with videos related to
Sort By:
Page
of 7
Plos Genetics
|
June 28, 2008
Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma
Anna Foryst-Ludwig, Markus Clemenz, Stephan Hohmann, et al.
Clinical Lung Cancer
|
March 2, 2021
Pembrolizumab as First-Line Palliative Therapy in PD-L1 Overexpressing (≥ 50%) NSCLC: Real-world Results with Special Focus on PS ≥ 2, Brain Metastases, and Steroids
Nikolaj Frost, Jens Kollmeier, Daniel Misch, et al.
Current Oncology (Toronto, Ont.)
|
December 24, 2025
Independent Validation of a Machine Learning Classifier for Predicting Mediastinal Lymph Node Metastases in Non-Small Cell Lung Cancer Using Routinely Obtainable [<sup>18</sup>F]FDG-PET/CT Parameters
Agata Wdowiak, Julian M M Rogasch, Georg L Baumgärtner, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 23, 2023
A machine learning tool to improve prediction of mediastinal lymph node metastases in non-small cell lung cancer using routinely obtainable [<sup>18</sup>F]FDG-PET/CT parameters
Julian M M Rogasch, Liza Michaels, Georg L Baumgärtner, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 22, 2019
Next generation sequencing of lung adenocarcinoma subtypes with intestinal differentiation reveals distinct molecular signatures associated with histomorphology and therapeutic options
Philipp Jurmeister, Claudia Vollbrecht, Anke Behnke, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 17, 2021
FDG-PET/CT for pretherapeutic lymph node staging in non-small cell lung cancer: A tailored approach to the ESTS/ESMO guideline workflow
Julian M M Rogasch, Nikolaj Frost, Stephanie Bluemel, et al.
BMC Health Services Research
|
July 3, 2025
Recruiting patients into a healthcare services trial: lessons learned from a feasibility study to investigate a patient-oriented navigation intervention for age-associated diseases
Kathrin Gödde, Hella Fügemann, Ulrike Grittner, et al.
JAMA Network Open
|
April 29, 2022
Effectiveness of Immune Checkpoint Inhibition vs Chemotherapy in Combination With Radiation Therapy Among Patients With Non-Small Cell Lung Cancer and Brain Metastasis Undergoing Neurosurgical Resection
David Wasilewski, Josefine Radke, Ran Xu, et al.
Current Medical Research and Opinion
|
September 1, 2022
Prophylaxis of chemotherapy-induced neutropenia with lipegfilgrastim in patients with lung cancer: final results from the non-interventional study NADIR
Christian Geßner, Thomas Fietz, Christoph Losem, et al.
Therapeutic Advances in Medical Oncology
|
June 9, 2022
Clinical predictors of survival in patients with relapsed/refractory small-cell lung cancer treated with checkpoint inhibitors: a German multicentric real-world analysis
Jan A Stratmann, Radha Timalsina, Akin Atmaca, et al.
Page
of 7